Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Oct 27, 2024; 16(10): 3094-3103
Published online Oct 27, 2024. doi: 10.4240/wjgs.v16.i10.3094
Exploring the landscape of minimally invasive pancreatic surgery: Progress, challenges, and future directions
Greta Donisi, Alessandro Zerbi
Greta Donisi, Alessandro Zerbi, Department of Biomedical Sciences, Humanitas University, Pieve Emanuele 20090, Milan, Italy
Greta Donisi, Alessandro Zerbi, Department of Pancreatic Surgery, IRCCS Humanitas Research Hospital, Rozzano 20089, Milan, Italy
Author contributions: Zerbi A and Donisi G contributed to this paper; Zerbi A designed the overall concept and outline of the manuscript; Donisi G contributed to the discussion and design of the manuscript; Zerbi A and Donisi G contributed to the writing, and editing the manuscript, illustrations, and review of literature.
Conflict-of-interest statement: Greta Donisi and Alessandro Zerbi have nothing to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Greta Donisi, MD, Academic Fellow, Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele 20090, Milan, Italy. greta.donisi@humanitas.it
Received: May 27, 2024
Revised: July 9, 2024
Accepted: July 15, 2024
Published online: October 27, 2024
Processing time: 123 Days and 11.3 Hours
Core Tip

Core Tip: Implementation of minimally invasive pancreatic surgery (MIPS) is a process that cannot be stopped. Minimally invasive (MI) distal pancreatectomy is now well-supported by evidence showing its safety and potential superiority over open surgery. Although the feasibility and definitive evidence for MI pancreaticoduodenectomy (MIPD) remain under investigation, high-volume centers have reported promising outcomes. The rise of robotic pancreatic surgery is poised to overcome technical limitations and enhance the transition to MIPD. Ensuring patient safety through rigorous monitoring and structured training of surgeons is crucial for the continued safe implementation of MIPS.